AcquisitionOther
Telomir Pharmaceuticals acquired TELI Pharmaceuticals
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Telomir Pharmaceuticals -> TELI Pharmaceuticals · 34,389,710 restricted shares plus $1 million cash
To establish Telomir as the sole holder of global rights to Telomir-1 and consolidate telomerase-based therapeutic development.
Open source record (SEC) ↗